ERBB2 and breast carcinoma: We selected immune cells with the most different infiltration under TNBC, Her2, ER, and PR groups, respectively, resulting in 16 immune cells with distinct infiltration among Her2, ER, and PR expression in breast cancer (Fig. 5C-F).